Display Settings:

Format

Send to:

Choose Destination
    Rheumatology (Oxford). 2010 May;49 Suppl 2:ii18-ii23.

    Identifying and assessing benefit-risk in primary care--a family physician's perspective.

    Source

    Crowfoot Village Family Practice, #210, 600 Crowfoot Crescent NW, Calgary ABT3G0B4, Canada. raward@direct.ca

    Abstract

    For the family physician, NSAIDs, both traditional and cyclo-oxygenase-2 inhibitors, are a valuable contribution to managing arthritis and other rheumatological conditions in primary care. Yet, many of the patients seen by the family doctor have complex comorbidities and polypharmacy issues. This review looks at the main considerations for primary-care physicians while choosing an anti-inflammatory treatment for a hypothetical patient case study. In addition to looking at the evidence for gastrointestinal and cardiovascular risk, the concomitant use of aspirin with an NSAID is also examined. New evidence for interaction between selective serotonin re-uptake inhibitors is reviewed and the interaction between angiotensin-converting enzyme inhibitors and NSAIDs is considered. Making careful judgements based on individual needs, medical history and comorbidities is recommended based on the evidence reviewed.

    PMID:
    20407137
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2857793
    Free PMC Article

    Images from this publication.See all images (1) Free text

    F ig . 1

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk